San Francisco, CA -(PRNewswire)- CompWest Insurance Company, a subsidiary of Accident Fund Holdings, Inc., recently announced the appointment of Gene J. Simpson as vice president of Underwriting and Marketing.
Simpson recently joined CompWest’s senior management team and is responsible for company-wide underwriting and marketing practices. In this position, Simpson coordinates the development and implementation of company underwriting and marketing programs; manages and directs the execution of all sales plans and production initiatives; as well as the research, strategy and implementation of new markets.
“The CompWest team has made significant strides in stabilizing our financial results, despite challenging environmental factors,” Bryan Bogardus, president of CompWest Insurance Company, said. “As we look forward, we see a significant role for CompWest in the workers’ compensation marketplace and the addition of Gene is an investment in our future. Gene has a proven track record of developing and deploying successful go-to-market strategies and he is excited about working with our employees and partner brokers to grow our company.”
Simpson most recently served as vice president of Workers’ Compensation Product Management for Seabright Holdings, Inc. Prior to that, he served as vice president of General Liability and Product Line Manager for Liberty Mutual Insurance and for 11 years in a variety of capacities for Safeco Insurance Company, including assistant vice president of Product Development,; assistant director of Workers’ Compensation; commercial manager of National Programs and commercial underwriter of Multiline and Workers’ Compensation.
Simpson graduated from Western Washington University with a Bachelor of Science in applied mathematics and holds the designations of Chartered Property Casualty Underwriter (CPCU) and Certified Insurance Counselor (CIC). Simpson is an active member of his community, participating in various fundraising efforts to support several charitable organizations with a particular interest in Susan G. Komen for the Cure.
Source: PRNewswire